Prognostic and Predictive Biomarkers in Familial Breast Cancer
Details
Publication Year 2023,Volume 15,Issue #4,Page 1346
Journal Title
Cancers
Publication Type
Review
Abstract
Large numbers of breast cancers arise within a familial context, either with known inherited germline mutations largely within DNA repair genes, or with a strong family history of breast and/or ovarian cancer, with unknown genetic underlying mechanisms. These cancers appear to be different to sporadic cases, with earlier age of onset, increased multifocality and with association with specific breast cancer histological and phenotypic subtypes. Furthermore, tumours showing homologous recombination deficiency, due to loss of BRCA1, BRCA2, PALB2 and CHEK2 function, have been shown to be especially sensitive to platinum-based chemotherapeutics and PARP inhibition. While there is extensive research and data accrued on risk stratification and genetic predisposition, there are few data pertaining to relevant prognostic and predictive biomarkers within this breast cancer subgroup. The following is a review of such biomarkers in male and female familial breast cancer, although the data for the former are particularly sparse.
Publisher
MDPI
Department(s)
Pathology; Laboratory Research
PubMed ID
36831687
Open Access at Publisher's Site
https://doi.org/10.3390/cancers15041346
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-04-06 06:53:44
Last Modified: 2023-04-17 11:52:08

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙